Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medtronic (NY:MDT)

80.91 -3.50 (-4.15%)
Official Closing Price Updated: 7:00 PM EDT, May 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Top S&P500 movers in Thursday's session
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session. 
Via Chartmill
5 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Thursday's session: gap up and gap down stock in the S&P500 index
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends. 
Via Chartmill
2 Stocks That Turned $1,000 Into More Than $8,000 in 10 Years to Buy and Hold
Via The Motley Fool
A Preview Of Medtronic's Earnings
Via Benzinga
Wall Street Stalls As Yields Rise, Bitcoin Breaks Records Above $109,000: What's Driving Markets Wednesday?
U.S. equities trading was mixed on Wednesday, with major indices showing limited movement by midday as investors remained cautious amid renewed concerns over fiscal policy, which pressured Treasury... 
Via Benzinga
Topics Bonds
Exposures Debt Markets
Moderna Pulls Application For Seasonal Flu, Covid Combination Vaccine: But Retail Gets More Bullish
Moderna will resubmit the application later this year after data from its ongoing late-stage trial of its seasonal flu vaccine is available. 
Via Stocktwits
Exposures COVID-19 Product Safety
XPeng Stock Rises Pre-Market On Upbeat Q1 Earnings, Strong Q2 Forecast: Retail Turns Bullish
For the second quarter, XPeng expects to deliver between 102,000 and 108,000 vehicles, representing a YoY increase of as much as 257.5%. 
Via Stocktwits
Medtronic Dips Despite Quarterly Beat On Plans To Spin Off Diabetes Business
The company beat quarterly expectations and issued strong earnings guidance. But the spinoff plans sent shares lower. 
Via Investor's Business Daily
Topics Government World Trade
Exposures COVID-19 Political Product Safety
Medtronic Beats Q4 Forecasts, Hikes Dividend, Plans Diabetes Spinoff
Medtronic plc reported fourth-quarter 2025 sales of $8.93 billion, beating the consensus of $8.82 billion. 
Via Benzinga
Medtronic Announces Split Of Diabetes Business As Standalone Public Company: Retail’s Unmoved
The separation is expected to be accretive to Medtronic’s earnings and operating margin, the company said. 
Via Stocktwits
Topics World Trade
Exposures Tariff
Earnings Scheduled For May 21, 2025
Via Benzinga
Nasdaq, S&P 500 Futures Lower After Market Snaps 6-Day Rally: Strategist Warns Tariff-Induced ‘Growth Scare’ Still In Play
On Tuesday, nine of the 11 sector classes closed in the red, with the defensive consumer staple, utility and healthcare stocks bucking the downtrend. 
Via Stocktwits
Topics ETFs Economy Stocks
Exposures Fossil Fuels Interest Rates Tariff
Lifeward Appoints Mark Grant As New CEO: Retail Sentiment Dips
Most recently, Grant was President of the Americas and Chief Commercial Officer of IMRA Surgical, a provider of surgical robotic training. 
Via Stocktwits
Exposures Product Safety
5 Analysts Assess Medtronic: What You Need To Know
Via Benzinga
Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
Here are three dividend-paying stocks that warrant closer examination. 
Via The Motley Fool
Exposures COVID-19
Is MEDTRONIC PLC (NYSE:MDT) a Good Fit for Dividend Investing?
Why MEDTRONIC PLC (NYSE:MDT) qualifies as a good dividend investing stock. 
Via Chartmill
With Competition Rising, Should Investors Give Up On This Top Growth Stock?
Via The Motley Fool
Exposures Product Safety
2 Stocks I Can't Wait to Buy During the Next Market Correction
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
This Magnificent High-Yield Dividend Stock Just Became an Even Better Buy
Via The Motley Fool
Exposures Product Safety
Medtronic PLC (NYSE:MDT): A Strong Growth Stock with Technical Breakout Potential
Medtronic PLC (NYSE:MDT): A Strong Growth Stock with Technical Breakout Potential 
Via Chartmill
2 Outstanding Dividend Stocks to Buy and Hold For 20 Years
Via The Motley Fool
Topics Government World Trade
Exposures Political Tariff
Cowper Law LLP Defeats Medtronic's Motion for Summary Judgment in MiniMed Insulin Pump Litigation
Cowper Law LLP Defeats Medtronic's Motion for Summary Judgment in MiniMed Insulin Pump Litigation 
Via News Direct
Exposures Product Safety
The Smartest Dividend Stocks to Buy With $2,000 Right Now
Via The Motley Fool
Topics Bonds
Exposures Debt Markets
Medtronic: A Dividend Aristocrat With Stability and Innovation
Medtronic delivers consistent dividend growth and healthcare innovation, positioning it as a stable investment choice in today's dynamic market environment. 
Via MarketBeat
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
Healthcare sector sees volatility due to UnitedHealth's earnings disappointment, but ETFs like XLV, IHE, and XPH still show resilience and pockets of strength. 
Via Benzinga
Topics ETFs
Elon Musk’s Neuralink Faces New FDA-Approved Rival In Precision Neuroscience
The device, known as the Layer 7 Cortical Interface, is a thin, flexible microelectrode array designed to record and stimulate neural activity without penetrating brain tissue. 
Via Stocktwits
Topics Artificial Intelligence ETFs Government
Exposures Artificial Intelligence Political Product Safety
Nvidia Drags Wall Street Down, Gold Defies Gravity Ahead Of Powell Remarks: What's Driving Markets Wednesday?
U.S. major indices traded lower at midday Wednesday, pressured by sharp declines in tech and semiconductor stocks after Washington tightened chip export restrictions to China. 
Via Benzinga
Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device
Dexcom stock surged Thursday after the FDA cleared its newest diabetes device for an extended 15-day wear time. 
Via Investor's Business Daily
Topics Government Stocks World Trade
Exposures Political Product Safety Tariff
< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.